Professional Documents
Culture Documents
Year 1989, P&G stepped out for head-on with J&J in the sanitary napkin market.
With great technology, it revolutionized the Indian feminine hygiene market with
the brand Whisper against the Stayfree of J&J. It was then that the Silky Dry
variant was launched to compete with the superior technology of the Whisper
brand. But the Silky Dry variant was not able to compete on value-for-money
with Whisper as consumers were unwilling to pay a premium for the product. The
target market was mid-segment. The next entry was in the detergent market
with the brand Ariel. The lucrative growth in India represented a mouth-watering
proposition to P&G International that has increased its stake in Procter & Gamble
India to 51% and then to 65%. In 1993, Procter & Gamble India divested the
Detergents business to Procter & Gamble Home Products. In the same year P&G
India started marketing Old Spice Brand of products. To perfectly fit in its
corporate strategy, Procter & Gamble India Limited changed the name of the
Company to Procter & Gamble Hygiene and Health Care Limited. In the same
year Mediker Shampoo business was divested to Marico Industries. This step of
P&G revealed the mind set of the company to follow the niche strategy. The
focus was on three brands; Ariel, Vicks, and Whisper. In 1999, on one side, P&G’s
Vicks Action 500 (OTC) was covered with Coldarin umbrella of J&J (with two brand
extensions; Coldarin Plus and Coldarin Cough & Cold with total market share of
nearly 3.2 %). Another side was D’Cold from Paras. Reckitt Piramal, the
marketing JV of Reckitt & Colman with Nicholas Piramal, was gearing up to
launch Disprin Cough and Flu tablets. Its not that competition was restricted to
OTC brands, Glaxo’s brand Actifed was eating up the share but through the
prescription route. In 2000, Procter & Gamble Hygiene and Health Care Limited
introduced Whisper Ultra - a revolutionary and unique product in the history of
menstrual products in India for premium segment. J&J, the then market leader,
with out losing time counter-attacked with Stayfree Sure and other ultrathin sub
brands**. The mid segment market was threatened by low-priced sanitary
napkins (from ambitious contenders such as Johnson and Johnson and Kimberly
Clark Lever).
In August 2000, the next extension was Vicks Plus Medicated Lozenges, a
product that provides medicinal relief from sore throat. The plan was to add new
consumer base to the existing one. The USP of Vicks Plus Medicated Lozenges
lies in its anti-bacterial ingredient CPC (Cetylpyridinium Chloride), which actually
provides medicinal relief from a sore throat. The over all strategy was to increase
entry barriers in cold and cough market and to invade in the mid and premium
segment of menstrual products with break through technology. The basic
strategy pivots around bifurcation of brands that will be in competition and that
will be away. The differentiation strategy was not sufficient In Indian market to
generate volume sales so the next move was to focus on cost. The targeted area
was its distribution channel, making it more cost-effective and streamlining the
distribution channels to focus on the promising markets alone. Initiative to follow
the first principle of generic strategies for cost-focus worked for P&G. Year-ended
June 2000, witnesses 100% profit growth. It was clear that the launch of the
product from the parent will be streamline to the respective SBU. Tide detergent
and Tempo tissues from the P&G Worldwide was routed in Indian through solely
own subsidiary of parent. Only Tampax -- a feminine hygiene brand -- was
through PGHH. In August 2000, Vicks Action 500+ was relaunched in an
attractive True Blue pack. The change in packing color from green to blue was to
inline the products with the international brands.
In April 2001, Procter & Gamble Hygiene and Health Care Limited reduced the
prices of Whisper Ultra from Rs.80 to Rs.65 for a pack of ten, making it affordable
to Indian consumers. This was to fade the effect of competitors in premium
market. After nine months J&J decided to phase out its Stayfree Silky Dry sub-
brand in the wake of launching its latest offering in the premium end of the
market -Stayfree Sure. P&G took the different route to influence consumers in
sanitary napkin market .In May 2002; Whisper announced a unique knowledge
sharing initiative for women, The Whisper Diary of Secrets. The story did not end
there. With the killer instinct PGHH announced the launch of
Whisper “Money Back” offer. No performance experience will return the money.
In June 2002, Vicks VapoRub was repositioned on multiple benefits. The USP was
six symptoms relief of a child cold, namely blocked nose, cough, body ache,
headache, muscle-stiffness and breathing difficulty. The target consumer
segment was children. The benefit was faster, longer-lasting relief from these six
symptoms of cold. This phase was of differentiation of queen brand. The step
was to outfit intruders like D’Cold, Amrutanjan and Acti-V from Nestle which
introduced in two variants — honey lemon and menthol eucalyptus. Quite
ridiculous Nestle jumped in this market. The underline fact is that all the
products were ayurvedic and natural. In July 2002, Procter & Gamble announced
the launch of Vicks Action500+ Night tablets, a specially designed cold medicine
that gives consumers multi-symptom relief from bothersome cold symptoms like
headache and breathing difficulty, hence allowing restful sleep at night. Don’t
ask more about it as I can’t explain to you why it was a big flop. Next we will
cover the story beyond 2002. About feminine health and hygiene market and
more on competitive side of VICKS we will cover in different articles. If its in use
for you in coming days, please request an article.